rs2229431 — INSR

INSR Exon 13 — Insulin Receptor Signaling and Brain Health

The insulin receptor (INSR) does far more than regulate blood sugar. Expressed in neurons throughout the brain — particularly in the hippocampus, hypothalamus, and prefrontal cortex — the insulin receptor plays a role in synaptic plasticity¹¹ synaptic plasticity
The strengthening or weakening of synaptic connections in response to activity; essential for memory formation and learning, dopamine signaling, and neuronal survival. When insulin receptor signaling is impaired in the brain, the consequences extend well beyond glycemia into cognitive function and psychiatric vulnerability.

rs2229431 is a synonymous variant in exon 13 of INSR — meaning the DNA sequence changes but the encoded amino acid (asparagine at position 865) does not. The variant is classified as benign by ClinVar in the context of classic insulin receptor disorders (leprechaunism, Rabson-Mendenhall syndrome). However, synonymous variants are not necessarily functionally silent: they can alter mRNA splicing efficiency²² mRNA splicing efficiency
The process of removing introns from pre-mRNA; synonymous variants near splice sites or in exonic splicing enhancers can shift the ratio of alternatively spliced isoforms, mRNA stability, and translational kinetics. Exon 13 encodes part of the region that contributes to the intracellular beta subunit involved in tyrosine kinase autophosphorylation³³ tyrosine kinase autophosphorylation
The process by which the insulin receptor activates itself by adding phosphate groups to its own tyrosine residues; the initiating step of intracellular insulin signaling.

The Mechanism

INSR produces two splice isoforms — INSR-A (exon 11 excluded) and INSR-B (exon 11 included) — that differ in their affinity for insulin, insulin-like growth factor 2 (IGF-2), and other ligands. INSR-A predominates in neurons and fetal tissues; INSR-B predominates in the liver and skeletal muscle. Exon 13 encodes a segment of the intracellular beta subunit that participates in tyrosine kinase domain assembly⁴⁴ tyrosine kinase domain assembly
The region of INSR that executes the first steps of insulin signaling by phosphorylating downstream adaptor proteins including IRS-1 and IRS-2. A synonymous change in this exon could in principle alter local mRNA secondary structure, affect ribosomal elongation pausing, or subtly shift the ratio of correctly folded receptor at the cell surface. The precise molecular consequence of this specific variant has not been characterized in mechanistic studies.

The Evidence

The primary evidence linking rs2229431 to phenotype comes from two small studies by Melkersson and colleagues, both examining INSR gene variants in Swedish psychiatric cohorts.

Melkersson 2018⁵⁵ Melkersson 2018
Sequencing of the insulin receptor (INSR) gene reveals association between gene variants in exon and intron 13 and schizoaffective disorder. Neuro Endocrinol Lett, 2018 sequenced the complete INSR gene in 105 patients with schizophrenia or schizoaffective disorder and 60 controls. rs2229431 showed significant differences in genotype distribution between the three groups — but the association was driven specifically by schizoaffective disorder patients, who differed from both schizophrenia patients and controls. No specific p-values or odds ratios were reported in the abstract.

Melkersson & Persson 2023⁶⁶ Melkersson & Persson 2023
Associations between heredity, height, BMI, diabetes mellitus type 1 or 2 and gene variants in the insulin receptor (INSR) gene in patients with schizophrenia. Neuro Endocrinol Lett, 2023 followed up in 94 schizophrenia patients and 60 controls, identifying 50 INSR variants. Overall, no significant differences were found between all patients and controls, but in subgroup analysis rs2229431 tended to associate with family history of schizophrenia and significantly associated with height among patients.

A GWAS Catalog association also links the A allele to body height (beta = 0.0109 SDs, p = 7×10⁻¹⁵), a pleiotropic signal consistent with INSR's role in growth factor signaling during development. This height association provides independent evidence that the variant is not entirely neutral.

The evidence base is limited: two studies from a single research group, small sample sizes, no replication in independent cohorts, and no mechanistic characterization of the variant's molecular effect. This is firmly emerging-level evidence.

Practical Actions

For carriers of the A allele, the current evidence does not support any specific clinical intervention. The psychiatric associations require replication before clinical translation. What is actionable is ensuring that brain insulin signaling is optimally supported through lifestyle factors known to maintain insulin receptor sensitivity in neural tissue — particularly aerobic fitness and limiting chronic hyperglycemia, both of which independently modulate brain insulin receptor expression.

Given INSR's dual metabolic and neurological roles, carriers of the A allele have reason to monitor both metabolic health (fasting glucose, insulin) and cognitive health over time, and to discuss any family history of mood or psychotic disorders with a clinician.

Interactions

The intron 13 variant rs12610022, also identified by Melkersson 2018, showed near-significant differences in the same schizoaffective cohort — suggesting that the exon 13 and intron 13 regions of INSR may together form a functional haplotype relevant to neural insulin receptor expression or activity. The broader INSR gene context includes interactions with insulin signaling pathway components including IRS-1 (rs1801278) and IRS-2, though no compound heterozygosity data exist for rs2229431 specifically.